Related Experiment Video

Updated: Jul 4, 2025

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima
09:13

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Published on: August 12, 2018

14.9K

Leukemia and mitophagy: a novel perspective for understanding oncogenesis and resistance

Yueyao Liu1, Zhigui Ma2

  • 1Department of Pediatrics, West China Second University Hospital, Sichuan University, Sichuan Province, No. 20, Section 3, Renmin South Road, Chengdu, 610041, China.

Annals of Hematology
|January 28, 2024
PubMed

Insights

Mitophagy, the process of degrading damaged mitochondria, is crucial for cellular balance and plays a key role in cancer, particularly leukemia. Understanding mitophagy mechanisms may lead to new cancer therapies.

Area of Science:

  • Cellular Biology
  • Mitochondrial Dynamics
  • Autophagy

Background:

  • Mitophagy selectively degrades damaged mitochondria, maintaining cellular homeostasis.
  • Emerging evidence highlights mitophagy's role in cancer initiation, progression, and treatment.
  • Mitophagy regulates mitochondrial homeostasis and metabolism in hematopoietic stem cells (HSCs).

Purpose of the Study:

  • To elucidate the regulatory mechanisms of mitophagy.
  • To explore the intricate significance of mitophagy in leukemia.
  • To provide a molecular basis for targeted therapeutic interventions in cancer.

Main Methods:

  • Literature review and data integration.
  • Molecular pathway analysis.
  • Comparative study of mitophagy in normal and cancerous cells.

Main Results:

  • Mitophagy is a critical regulator of mitochondrial quality control.
  • Dysregulated mitophagy is implicated in various cancers, including leukemia.
  • Specific molecular pathways governing mitophagy in HSCs have been identified.

Conclusions:

  • Mitophagy is a key player in maintaining cellular and mitochondrial health.
  • Targeting mitophagy presents a promising therapeutic strategy for leukemia and other cancers.
  • Further molecular elucidation of mitophagy will drive innovative cancer treatments.
Keywords:
AutophagyHSCsLeukemiaMitophagyResistanceTherapy

More Related Videos

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K
An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

6.9K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.4K